Xlife Sciences AG (SWX:XLS)
Switzerland · Delayed Price · Currency is CHF 22.00
+0.60 (2.80%)
At close: Aug 12, 2025, 5:20 PM CET
Xlife Sciences AG Market Cap
Xlife Sciences AG has a market cap or net worth of 125.17 million as of August 14, 2025. Its market cap has decreased by -30.79% in one year.
Market Cap
125.17M
Enterprise Value
275.65M
Revenue
834.88K
Ranking
n/a
PE Ratio
4.81
Stock Price
22.00
Market Cap Chart
Since February 10, 2022, Xlife Sciences AG's market cap has decreased from 240.46M to 125.17M, a decrease of -47.95%. That is a compound annual growth rate of -16.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 115.98M | -20.47% |
| Dec 30, 2024 | 145.84M | -47.72% |
| Dec 29, 2023 | 278.96M | 77.76% |
| Dec 30, 2022 | 156.93M | -34.74% |
| Feb 10, 2022 | 240.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 211.38B |
| Novartis AG | 185.88B |
| Lonza Group AG | 38.23B |
| Alcon | 34.23B |
| Galderma Group AG | 31.53B |
| Sandoz Group AG | 20.26B |
| Straumann Holding AG | 16.02B |
| Sonova Holding AG | 13.35B |